Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198902 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Diego Alejandro Rodríguez Gutiérrez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Clínico y de Patología, Clínica Colsanitas, Bogotá 111321, Colombia. Hauptthemen laut MEDLINE: Exome Sequencing, Autism Spectrum Disorder. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a genetically heterogeneous condition; however, genomic data from Latin American populations remain limited. We investigated the molecular and phenotypic landscape of ASD in 916 Colombian patients who underwent whole-exome sequencing (WES) between 2022 and 2025. Clinical and genomic data were retrospectively analyzed, and phenotypes were standardized using Human Phenotype Ontology (HPO) terms. Variants were classified per ACMG/ClinGen guidelines, and we assessed phenotypic burden, predictors of molecular diagnosis, copy number variants (CNVs), and functional convergence of candidate genes. A molecular diagnosis was identified in 112 patients (12.2%), including 82 with variants in ASD-associated genes or regions and 30 with findings related to other clinical features. We identified 16 novel pathogenic/likely pathogenic variants, along with 10 CNVs. Among trio-based patients, 70.9% of molecular diagnoses were de novo. Higher phenotypic burden was associated with molecular diagnosis, and global developmental delay was the strongest predictor after correction for multiple testing. Functional enrichment analysis of candidate genes showed convergence on pathways related to neuronal development, synaptic function, and ion transport. These findings highlight the genetic and phenotypic heterogeneity of ASD and support the value of integrating standardized genomic and phenotypic characterization in Colombian populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio Clínico y de Patología, Clínica Colsanitas, Bogotá 111321, Colombia.
- Fundación Universitaria Sanitas, Bogotá 110141, Colombia.
ORCID-Profile: Paula Rueda-Gaitán, Natalia Gomez-Lopera, Juan Javier López Rivera
Zitieren
APA
Rodríguez Gutiérrez, D. A., Cárdenas Prieto, R., Rueda-Gaitán, P., Gomez-Lopera, N., Estrada-Serrato, C., Isaza-Ruget, M., & López Rivera, J. J. (2026). Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198902
Vancouver
Rodríguez Gutiérrez DA, Cárdenas Prieto R, Rueda-Gaitán P, Gomez-Lopera N, Estrada-Serrato C, Isaza-Ruget M, et al. Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198902
BibTeX
@article{RodrguezGutirrez2026,
author = {Rodríguez Gutiérrez, Diego Alejandro and Cárdenas Prieto, Ronald and Rueda-Gaitán, Paula and Gomez-Lopera, Natalia and Estrada-Serrato, Carlos and Isaza-Ruget, Mario and López Rivera, Juan Javier},
title = {Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198902}
}
EUVIMED